| 产品标题 |
产品货号 |
产品规格 |
厂家 |
| Human chromosome 5 open reading frame 56 (C5orf56), transcript variant 1, full length from ORIGENE TECHNOLOGIES | TP760357 | 50 ug | ORIGENE TECHNOLOGIES |
| Human chromosome 7 open reading frame 46 (C7orf46), transcript variant 1, full length from ORIGENE TECHNOLOGIES | TP760985 | 50 ug | ORIGENE TECHNOLOGIES |
| Human chromosome 9 open reading frame 72 (C9orf72), transcript variant 1, full length from ORIGENE TECHNOLOGIES | TP760931 | 50 ug | ORIGENE TECHNOLOGIES |
| Human chromosome 19 open reading frame 63 (C19orf63), transcript variant HSS1, full length from ORIGENE TECHNOLOGIES | TP760930 | 50 ug | ORIGENE TECHNOLOGIES |
| Human chromosome 15 open reading frame 23 (C15orf23), transcript variant 3, mutant (S24F) from ORIGENE TECHNOLOGIES | TP701005 | 20 ug | ORIGENE TECHNOLOGIES |
| Human chromosome 15 open reading frame 23 (C15orf23), transcript variant 3, mutant (S24F) from ORIGENE TECHNOLOGIES | TP701003 | 20 ug | ORIGENE TECHNOLOGIES |
| Human chromosome 19 open reading frame 63 (C19orf63), transcript variant HSS1 from ORIGENE TECHNOLOGIES | TP315076 | 20 ug | ORIGENE TECHNOLOGIES |
| Human pim-1 oncogene (PIM1) from ORIGENE TECHNOLOGIES | TP305853 | 20 ug | ORIGENE TECHNOLOGIES |
| Human pim-2 oncogene (PIM2) from ORIGENE TECHNOLOGIES | TP301933 | 20 ug | ORIGENE TECHNOLOGIES |
| Human pim-3 oncogene (PIM3) from ORIGENE TECHNOLOGIES | TP312690 | 20 ug | ORIGENE TECHNOLOGIES |
| SHCBP1 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN205527LP | 1 kit | ORIGENE TECHNOLOGIES |
| SHCBP1 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN205527 | 1 kit | ORIGENE TECHNOLOGIES |
| SHCBP1 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN205527BN | 1 kit | ORIGENE TECHNOLOGIES |
| SHCBP1 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN205527RB | 1 kit | ORIGENE TECHNOLOGIES |
| SHCBP1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN405527 | 1 kit | ORIGENE TECHNOLOGIES |
| Neogenin homolog 1 (chicken) (NEO1) from ORIGENE TECHNOLOGIES | LY400890 | 100 ug | ORIGENE TECHNOLOGIES |
| Human ER lipid raft associated 1 (ERLIN1) from ORIGENE TECHNOLOGIES | TP305137 | 20 ug | ORIGENE TECHNOLOGIES |
| Human ermin, ERM-like protein (ERMN), transcript variant 2 from ORIGENE TECHNOLOGIES | TP305430 | 20 ug | ORIGENE TECHNOLOGIES |
| Thyroid stimulating hormone receptor (TSHR), transcript variant 1 from ORIGENE TECHNOLOGIES | LY400133 | 100 ug | ORIGENE TECHNOLOGIES |
| Insulin receptor (INSR), transcript variant 1 from ORIGENE TECHNOLOGIES | LY424860 | 100 ug | ORIGENE TECHNOLOGIES |
| Insulin receptor (INSR), transcript variant 1 from ORIGENE TECHNOLOGIES | LY424988 | 100 ug | ORIGENE TECHNOLOGIES |
| Insulin receptor-related receptor (INSRR) from ORIGENE TECHNOLOGIES | LY415430 | 100 ug | ORIGENE TECHNOLOGIES |
| Insulin receptor substrate 1 (IRS1) from ORIGENE TECHNOLOGIES | LY417237 | 100 ug | ORIGENE TECHNOLOGIES |
| Insulin receptor substrate 2 (IRS2) from ORIGENE TECHNOLOGIES | LY418459 | 100 ug | ORIGENE TECHNOLOGIES |
| Thyroid hormone receptor interactor 10 (TRIP10) from ORIGENE TECHNOLOGIES | LY418125 | 100 ug | ORIGENE TECHNOLOGIES |
| Thyroid hormone receptor interactor 4 (TRIP4) from ORIGENE TECHNOLOGIES | LY414127 | 100 ug | ORIGENE TECHNOLOGIES |
| Thyroid hormone receptor interactor 6 (TRIP6) from ORIGENE TECHNOLOGIES | LY401139 | 100 ug | ORIGENE TECHNOLOGIES |
| Thyroid hormone receptor interactor 13 (TRIP13), transcript variant 1 from ORIGENE TECHNOLOGIES | LY418122 | 100 ug | ORIGENE TECHNOLOGIES |
| Thyroid hormone responsive (SPOT14 homolog, rat) (THRSP) from ORIGENE TECHNOLOGIES | LY401120 | 100 ug | ORIGENE TECHNOLOGIES |
| UDP-galactose-4-epimerase (GALE), transcript variant 1 from ORIGENE TECHNOLOGIES | LY424739 | 100 ug | ORIGENE TECHNOLOGIES |
| UDP-galactose-4-epimerase (GALE), transcript variant 2 from ORIGENE TECHNOLOGIES | LY423394 | 100 ug | ORIGENE TECHNOLOGIES |
| UDP-galactose-4-epimerase (GALE), transcript variant 3 from ORIGENE TECHNOLOGIES | LY426826 | 100 ug | ORIGENE TECHNOLOGIES |
| UDP-Gal:betaGlcNAc beta 1, 3-galactosyltransferase, polypeptide 2 (B3GALT2) from ORIGENE TECHNOLOGIES | LY401245 | 100 ug | ORIGENE TECHNOLOGIES |
| UDP-Gal:betaGlcNAc beta 1, 3-galactosyltransferase, polypeptide 4 (B3GALT4) from ORIGENE TECHNOLOGIES | LY418438 | 100 ug | ORIGENE TECHNOLOGIES |
| UDP-Gal:betaGlcNAc beta 1, 4- galactosyltransferase, polypeptide 1 (B4GALT1) from ORIGENE TECHNOLOGIES | LY400575 | 100 ug | ORIGENE TECHNOLOGIES |
| UDP-Gal:betaGlcNAc beta 1, 4- galactosyltransferase, polypeptide 3 (B4GALT3) from ORIGENE TECHNOLOGIES | LY401244 | 100 ug | ORIGENE TECHNOLOGIES |
| UDP-Gal:betaGlcNAc beta 1, 3-galactosyltransferase, polypeptide 1 (B3GALT1) from ORIGENE TECHNOLOGIES | LY412159 | 100 ug | ORIGENE TECHNOLOGIES |
| UDP-Gal:betaGlcNAc beta 1, 4- galactosyltransferase, polypeptide 5 (B4GALT5) from ORIGENE TECHNOLOGIES | LY417757 | 100 ug | ORIGENE TECHNOLOGIES |
| UDP-Gal:betaGlcNAc beta 1, 3-galactosyltransferase, polypeptide 5 (B3GALT5), transcript variant 1 from ORIGENE TECHNOLOGIES | LY416890 | 100 ug | ORIGENE TECHNOLOGIES |
| UDP-Gal:betaGlcNAc beta 1, 3-galactosyltransferase, polypeptide 5 (B3GALT5), transcript variant 2 from ORIGENE TECHNOLOGIES | LY409690 | 100 ug | ORIGENE TECHNOLOGIES |
| UDP-Gal:betaGlcNAc beta 1, 3-galactosyltransferase, polypeptide 5 (B3GALT5), transcript variant 2 from ORIGENE TECHNOLOGIES | LY429857 | 100 ug | ORIGENE TECHNOLOGIES |
| UDP-Gal:betaGlcNAc beta 1, 3-galactosyltransferase, polypeptide 5 (B3GALT5), transcript variant 3 from ORIGENE TECHNOLOGIES | LY409691 | 100 ug | ORIGENE TECHNOLOGIES |
| UDP-Gal:betaGlcNAc beta 1, 3-galactosyltransferase, polypeptide 5 (B3GALT5), transcript variant 3 from ORIGENE TECHNOLOGIES | LY429858 | 100 ug | ORIGENE TECHNOLOGIES |
| UDP-Gal:betaGlcNAc beta 1, 3-galactosyltransferase, polypeptide 5 (B3GALT5), transcript variant 4 from ORIGENE TECHNOLOGIES | LY429859 | 100 ug | ORIGENE TECHNOLOGIES |
| UDP-Gal:betaGlcNAc beta 1, 3-galactosyltransferase, polypeptide 5 (B3GALT5), transcript variant 4 from ORIGENE TECHNOLOGIES | LY409692 | 100 ug | ORIGENE TECHNOLOGIES |
| UDP-Gal:betaGlcNAc beta 1, 4- galactosyltransferase, polypeptide 2 (B4GALT2), transcript variant 2 from ORIGENE TECHNOLOGIES | LY418436 | 100 ug | ORIGENE TECHNOLOGIES |
| UDP-Gal:betaGlcNAc beta 1, 3-galactosyltransferase, polypeptide 5 (B3GALT5), transcript variant 5 from ORIGENE TECHNOLOGIES | LY409693 | 100 ug | ORIGENE TECHNOLOGIES |
| UDP-Gal:betaGlcNAc beta 1, 4- galactosyltransferase, polypeptide 2 (B4GALT2), transcript variant 3 from ORIGENE TECHNOLOGIES | LY423722 | 100 ug | ORIGENE TECHNOLOGIES |
| UDP-Gal:betaGlcNAc beta 1, 3-galactosyltransferase, polypeptide 5 (B3GALT5), transcript variant 5 from ORIGENE TECHNOLOGIES | LY429860 | 100 ug | ORIGENE TECHNOLOGIES |
| UDP-Gal:betaGlcNAc beta 1, 4- galactosyltransferase, polypeptide 2 (B4GALT2), transcript variant 3 from ORIGENE TECHNOLOGIES | LY425140 | 100 ug | ORIGENE TECHNOLOGIES |